C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
11/2002
11/19/2002	US6482774 Substituted (4-brompyrazole-3-yl) benzazoles
11/19/2002	US6482483 Phosphonium salt composition
11/19/2002	CA2098999C 5-sulfonyl-substituted benzotriazole uv-absorbers and stabilized compositions
11/14/2002	WO2002090560A2 Process for the production of phospholipids
11/14/2002	WO2002090368A1 Process to prepare a multidentate phosphine compound
11/14/2002	WO2002090367A1 Process for the preparation of 4-amino-1-hydroxybutylidene-1, 1-biphosphonic acid
11/14/2002	WO2002090354A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides
11/14/2002	WO2002090313A1 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies
11/14/2002	WO2002090304A1 Stable solution of reduced coenzyme q
11/14/2002	WO2002067913A8 (z)-styrylbenzylsulfones and pharmaceutical uses thereof
11/14/2002	WO2002064616A3 Agonists and antagonists of sphingosine-1-phosphate receptors
11/14/2002	WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002	US20020169340 Phosphole and diphosphole ligands for catalysis
11/14/2002	US20020169335 Process for producing bismuth tertiary amyloxide
11/14/2002	US20020169314 Sulfonamide derivative as a matrix metalloproteinase inhibitor
11/14/2002	US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives
11/14/2002	US20020168527 Novel hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom
11/13/2002	EP1256585A1 Process fot preparing 9-(2-(diethylphosphonomethoxy)ethyl)-adenine
11/13/2002	EP1256584A1 Process for preparing adefovir dipivoxil
11/13/2002	EP1255762A1 Phosphororganic compounds and the use thereof
11/13/2002	EP1255761A1 Silicon containing compounds from michael - type addition reactions useful as monomers and macromers
11/13/2002	EP1255570A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
11/13/2002	EP1098899B1 Bis-phosphinimine catalyst
11/13/2002	EP0846119B1 Thienopyrimidine derivatives, their production and use as endothelin antagonists
11/13/2002	EP0748320B1 Prodrugs of morpholine tachykinin receptor antagonists
11/13/2002	CN1379032A Heptahydrated fosphenytoin and its preparing process
11/13/2002	CN1094127C Substituted picolyl phosphoric acid ester with insecticidal activity and its prepn. method
11/12/2002	US6479688 From reacting tert-butylhydroquinone and monophenyl dichlorophosphate in presence of acid catalyst; flame retardants
11/12/2002	US6479687 Preparation of vinylphosphonic acid compounds
11/12/2002	US6479673 Antiretroviral enantiomeric nucleotide analogs
11/12/2002	US6479656 Phosphorylation process and catalyst
11/12/2002	US6479517 Treatment of post-menopausal syndrome: osteoporosis, cardiovascular effects such as hyperlipidemia, and estrogen-dependent cancer, particularly breast and uterine cancer
11/12/2002	US6479489 Substituted spiroheterocyclic 1H-3-arylpyrrolidine-2,4-dione derivatives, methods of preparing them and their use as pest-control agents
11/12/2002	US6479472 Methods of using therapeutic phospholipid derivatives
11/12/2002	US6479471 Novel phosphonate derivatives, hydroxyphosphinyl derivatives, and phosphoramidate derivatives that inhibit n-acetylated .alpha.-linked acidic dipeptidase (naaladase) enzyme activity to treat prostate diseases
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/12/2002	US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002	CA2202239C Liquid absorbent solutions for separating nitrogen from natural gas
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/07/2002	WO2002088151A1 Polymerizable phosphoric ester and process for producing the same
11/07/2002	WO2002088150A1 Phosphoric acid esters
11/07/2002	WO2002088149A2 A process for manufacture of fosinopril sodium
11/07/2002	WO2002087465A2 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	WO2001042243A3 Protein kinase inhibitors
11/07/2002	US20020165411 Sterically hindered phosphine ligands and uses thereof
11/07/2002	US20020165400 Antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex; thrombolytic agents
11/07/2002	US20020165324 Contact lens material
11/07/2002	US20020165228 Antiproliferative agents; antidiabetic agents
11/07/2002	US20020165218 Mixture of kinase inhibitor and anticancer agents
11/07/2002	US20020165205 Polyalkylene oxide-modified phospholipid and production method thereof
11/07/2002	US20020165200 Central nervous system disorders
11/07/2002	US20020164577 Detection of transmembrane potentials by optical methods
11/07/2002	US20020164289 Medical diagnosis
11/07/2002	CA2445565A1 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	CA2411876A1 A process for manufacture of fosinopril sodium
11/06/2002	EP1254910A1 Process to prepare a multidentate phosphine compound
11/06/2002	EP1254909A1 Esters of phosphoric acid
11/06/2002	EP1254885A1 Process for preparing optically active secondary alcohols having nitrogenous or oxygenic functional groups
11/06/2002	EP1254144A1 Novel phosphorus compounds
11/06/2002	EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1161437B1 Phosphabenzene compounds and their use as ligands for hydroformylation catalysts
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/06/2002	EP1109818B1 Phosphoepoxides, method for making same and uses
11/06/2002	EP1097159B1 Phosphinous and phosphonic acid derivatives used as medicaments
11/06/2002	EP1091966B1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace)
11/06/2002	EP1047669B1 Perfluoro-n-alkylsulfonic acid derivatives
11/06/2002	EP0919562B1 Phosphonate nucleotide compounds
11/06/2002	EP0837682B1 Therapeutic use of 1-amino-3-(n,n-dimethylamino)-propyliden-1,1-bisphosphonic acid and its salts
11/06/2002	EP0711300B1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/06/2002	CN1378450A Novel class of cytodifferentiating agents and histone deactylase inhibitors, and methods of use thereof
11/05/2002	US6476273 Method for producing phosphonium phenolates
11/05/2002	US6476272 Organophosphines
11/05/2002	US6476256 Process and apparatus for preparation of phosphorus oxyacids from elemental phosphorus
11/05/2002	US6476246 Unsymmetrical bicycloaliphatic chiral diphosphines and phosphine phosphinites, complexes of these compounds with metals of groups viib, viiib and ib as hydrogenation catalysts
11/05/2002	US6476216 Preparation of phosphorothioate oligomers
11/05/2002	US6476029 7-alkyl- and cycloalkyl-substituted imidazotriazinones
11/05/2002	US6475985 Nucleosides with antiviral and anticancer activity
11/05/2002	US6475347 High boiling inhibitors for distillable, polymerizable monomers
10/2002
10/31/2002	WO2002085919A1 Method of producing fluoroalkylphosphates
10/31/2002	WO2002085918A1 A facile synthesis of symmetric esters of alkylenebisphosphonic acids
10/31/2002	WO2002085860A1 Pyrazole derivatives for treating hiv
10/31/2002	WO2002085848A2 Synthesis of pancratistatin prodrugs
10/31/2002	WO2002085838A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/31/2002	WO2002066485A3 Novel hydroxyaryl phosphine oxides, glycidyl ethers and epoxy compositions, composites and laminates derived therefrom
10/31/2002	US20020161265 To ketones and aldehydes, by reacting with alkali hypohalite under alkaline conditions, using selective heterogeneous oxidation catalyst insoluble in the reaction medium that has 4-oxy-2,2,6,6-tetramethylpiperidin-1-oxyl groups
10/31/2002	US20020161262 Use treating various medical conditions, including pain
10/31/2002	US20020161261 Ionic liquids and production and use thereof
10/31/2002	US20020161259 Catalyst comprising: a metal support comprising copper and a non-copper metal; and a copper-containing coating in specified amounts of copper; making N-(phosphonomethyl)glycine from monoethanolamine
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020161221 Ether type lipid a 1-carboxylic acid analogs
10/31/2002	US20020161220 Tetraphosphonate bicyclic trisanhydrides
10/31/2002	US20020161205 Basic structure N=P-C(=M)-P=N where P is phosphorus, N is nitrogen, M is a transition or lanthanide metal and P,M and N atoms are substituted; making complex by reacting the corresponding diilithium salt with a metal compound
10/31/2002	US20020161034 Spiro-pyran compounds; use as pesticides and herbicides
10/31/2002	US20020160501 Methods for generating high titer helper-free preparations of released recombinant AAV vectors
10/31/2002	US20020160273 New organic borate compounds and the nonaqueous electrolytes and lithium secondary batteries using the compounds
10/31/2002	DE10132654A1 Phosphorhaltige, organisch polymerisierbare Silane und damit hergestellte Kieselsäure-Polykondensate Phosphorus-containing organic polymerizable silanes and silica polycondensation products produced thereby
10/31/2002	DE10114868C1 Verfahren zur Herstellung von Diphosphinen und deren Verwendung A process for preparing diphosphines and their use
10/31/2002	CA2444471A1 Synthesis of pancratistatin prodrugs
10/30/2002	EP1252170A2 Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate

1 ... 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 ... 554